Immune Regulation

Regcell

This biotechnology company develops regulatory T-cell therapies using an epigenetic reprogramming platform to treat patients with autoimmune diseases and inflammatory conditions.

Egle Therapeutics

This biotechnology company develops precision medicines that modulate regulatory T cells to treat patients with autoimmune diseases and cancer.

Dualyx

This company develops immune-modulating therapies targeting regulatory T cells to treat patients with autoimmune diseases.

Sonoma Biotherapeutics

This biotechnology company develops engineered regulatory T cell therapies for patients with autoimmune and inflammatory diseases.

Dualitas Therapeutics

The company develops bispecific antibody therapies for patients with autoimmune and allergic diseases using a cell-surface proximity screening engine.

Inimmune

The company develops immunotherapies and vaccine components to treat patients with allergies, cancer, infectious diseases and autoimmune conditions.

GentiBio

GentiBio develops engineered regulatory T cell therapies to restore immune tolerance for patients with autoimmune, alloimmune, autoinflammatory and allergic diseases.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.